Bristol-Myers Squibb Co (BMY)
57.76
+0.18
(+0.31%)
USD |
NYSE |
Dec 24, 16:00
Bristol-Myers Squibb Research and Development Expense (Quarterly): 2.374B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Amgen Inc | 1.45B |
Johnson & Johnson | 4.952B |
Eli Lilly and Co | 2.734B |
Merck & Co Inc | 5.862B |
Pfizer Inc | 2.598B |